Fundz

In Soma Bio, Inc. reported raising $50,000 in an initial SEC Form D filing, from an offering of $1 Million

PRIVATESep 03, 2020$50K of $1M raised

Amount Raised

$50,000

$50,000 sold, per SEC Form D (first sale Sep 3, 2020)

Round Type

Venture

DurhamBiotechnology

Who else raised in Biotechnology around the same time

Companies in the same sectors as inSoma Bio that raised within 45 days of this round, from Fundz verified event records.

  • Theromics raised $1M (Seed) on October 16, 2020.
  • Evofem Biosciences raised $25M on October 16, 2020.
  • Correlia Biosystems, Inc. raised $9.6M on October 16, 2020.
  • Alucent Biomedical, Inc. raised $35M on October 15, 2020.
  • ORTHO REGENERATIVE TECHNOLOGIES INC. raised $73K (Pre-Seed) on October 15, 2020.
  • Azitra raised an undisclosed amount (Series B) on October 15, 2020.

Who to call at inSoma Bio, and when

A new round usually means inSoma Bio is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day inSoma Bio raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at inSoma Bio, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at inSoma Bio. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

inSoma Bio

Location

701 W. Main Street, Suite 410

Durham, North Carolina, United States

About

inSoma Bio is a Duke University spinout and YC-backed company striving to build breast implants, personalized lumpectomy molds, and repair other soft tissue defects using a person’s own tissue without the need for major reconstructive surgery. We have developed an injectable gel that allows plastic surgeons to reliably build new tissue using a patient’s own liposuctioned fat without the need for synthetic implants or major reconstructive surgery.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment inSoma Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsStefan R., Executive Officer, DirectorSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for inSoma Bio's next move

See what Strategic adds

inSoma Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.